Hyperalbuminaemia after Bexagliflozin (Bexacat) in cats

59 reports to the FDA describe hyperalbuminaemia in cats given Bexagliflozin. That is 1.5% of all reports for this medicine, compared with 0.2% across reports for all cat medicines, so it is reported unusually often with this medicine.

59Reports

32%Marked serious

5.1%Recovered

10%Died or euthanised

30 daysTypical onset

How soon it started

Same day

2 4.1%

1–2 days

4 8.2%

3–7 days

6 12%

1–4 weeks

14 29%

Over a month

23 47%

How the animals did

Recovered

3 5.1%

Still unwell when reported

25 42%

Died

1 1.7%

Euthanised

5 8.5%

Not known

25 42%

Problems reported at the same time

28 47%

25 42%

24 41%

19 32%

Elevated cholesterol (total)

19 32%

Weight loss

18 31%

Loss of appetite

16 27%

Dehydration

16 27%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Bexagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Bexacat. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Bexagliflozin cause hyperalbuminaemia in cats?: 59 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 30 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperalbuminaemia with similar medicines

Hyperalbuminaemia after Velagliflozin (Senvelgo) 66 reports · 1.4% of its reports

All reported side effects of Bexagliflozin in cats · Medicines most reported with hyperalbuminaemia